Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HCK inhibitors for the treatment of fibrosis and cancer

HCK inhibitors for the treatment of fibrosis and cancer

US Patent 12441746 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HCK inhibitors for the treatment of fibrosis and cancer2025
Apparatus and method for inhibiting melatonin synthesis in a horse2025
Method for identifying kidney allograft recipients at risk for chronic injury2023
Method for diagnosing subclinical and clinical acute rejection by analysis of pr2023
Method for prediction of acute rejection and renal allograft loss using pre-tran2023
Use of SHROOM3 in chronic kidney disease and chronic allograft nephropathy2021
Method for identifying kidney allograft recipients at risk for chronic injury2021
Apparatus and method for inhibiting melatonin synthesis in a horse2021
Methods for diagnosing risk of renal allograft fibrosis and rejection2020
Method for predicting risk of exposure to interstitial fibrosis and tubular atro2020
Methods for diagnosing risk of renal allograft fibrosis and rejection2019
Optical comb filter having first, second and third GT resonant cavities2019